The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Put Hughes Syndrome on Your Radar

Put Hughes Syndrome on Your Radar

April 1, 2007 • By Graham R.V. Hughes, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Heart valves: One aspect of APS that separates it from other major clotting disorders is valvular disease. (See Table 1, p. 20.) The use of two-dimensional and Doppler echocardiography has shown a variety of lesions, including thrombotic vegetations, thickening, and stenosis. The mitral valve is by far the most commonly involved, with mitral regurgitation reported in up to one-fourth of all patients.

You Might Also Like
  • Why Antiphospholipid Antibody Syndrome Should Be On Your Radar
  • APS: What Rheumatologists Should Know about Hughes Syndrome
  • Antiphospholipid Syndrome
Explore This Issue
April 2007

The pathogenesis of valvular lesions is still uncertain. However, in some cases, a rapid combination of thrombosis and valvular degeneration leads to an early requirement for valve surgery.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Kidneys

The discovery of APS has had at least three important consequences in nephrology. First, it has altered the focus of renal biopsy in lupus to include renal microthrombosis. Second, it has proved an important prognostic (and therapeutic) indicator in renal transplantation. Third, it has revealed the interesting discovery of renal artery stenosis and hypertension associated with aPL.

Marie-Carmen Amigo, MD, and her colleagues at the Instituto Nacional de Cardiologia Ignacio Chavez in Mexico, did much to highlight the important contribution of renal microthrombosis to the pathological picture in lupus, with changes ranging from small occlusive arteriolar thrombotic lesions to severe renal artery hyperplasia and occlusion with renal parenchymal ischemia.8

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In renal transplantation, it is clear that patients with APS are at increased risk for post-transplant renal thrombosis and, importantly, that anticoagulant therapy could improve outcome.9 The important experience gained from observations of aPL on the outcome of renal transplantation has led to more routine aPL testing in the fields of liver, heart-lung, and marrow transplant surgery.

The link between renal artery stenosis and APS has been one of the most interesting and potentially one of the most important. In the 1983 description of APS, I reported “these patients’ blood pressure often fluctuates, apparently correlating with the severity of the livedo, suggesting a possible reno-vascular etiology. However, this group of patients rarely has primary renal disease.”2 Recently, my colleagues (notably Shirish Sangle, MD, and David D’Cruz, MD) have published a series of patients with renal artery stenosis and hypertension. In a cohort of 600 patients with aPL, 173 (29%) had definite hypertension requiring therapy.11 We have now built up a series of APS patients with renal artery stenosis, depicted in Figure 1. The lesions are localized and clearly differ from those of atheroma or fibro-muscular dysplasia.

With full anticoagulation, the hypertension in this group of patients proved easier to control. Interestingly, these focal stenotic arterial lesions are seen elsewhere in the body, for example, in the cerebral circulation and in the celiac and mesenteric arteries.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions Tagged With: Antiphospholipid Antibody Syndrome (APS), Autoimmune, Hughes Syndrome, Pathogenesis, TreatmentIssue: April 2007

You Might Also Like:
  • Why Antiphospholipid Antibody Syndrome Should Be On Your Radar
  • APS: What Rheumatologists Should Know about Hughes Syndrome
  • Antiphospholipid Syndrome
  • Advancements in Diagnosis, Treatment for Antiphospholipid Syndrome

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.